WallStreetZenWallStreetZen

NASDAQ: KNSA
Kiniksa Pharmaceuticals Ltd Earnings & Revenue

Buy KNSA

KNSA past revenue growth

How has KNSA's revenue growth performed historically?
Company
1,068.24%
Industry
1,120.72%
Market
118.92%
KNSA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KNSA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
KNSA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

KNSA earnings and revenue history

Current Revenue
$90.0M
Current Earnings
-$112.1M
Current Profit Margin
-124.5%

KNSA Return on Equity

Current Company
-62.4%
Current Industry
4.1%
Current Market
25.7%
KNSA's Return on Equity (-62.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when KNSA announces earnings.

KNSA Return on Assets

Current Company
-48.3%
Current Industry
3.4%
KNSA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KNSA Return on Capital Employed

Current Company
-65.42%
Current Industry
9.7%
KNSA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KNSA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KNSA$90.00M-$103.71M-$112.07M+1,068.24%N/A
TBPH$52.39M-$44.50M-$101.48M+10.81%N/A
ACLXN/AN/AN/AN/AN/A
SIGA$147.41M$92.53M$71.77M+47.26%-93.77%
PNT$0.00-$70.71M-$72.27MN/AN/A

KNSA earnings dates

Next earnings date
Oct 31, 2022

Kiniksa Pharmaceuticals Earnings & Revenue FAQ

What were KNSA's earnings last quarter?

On Invalid Date, Kiniksa Pharmaceuticals (NASDAQ: KNSA) reported Q2 2022 earnings per share (EPS) of -$0.29, up 52.46% year over year. Total Kiniksa Pharmaceuticals earnings for the quarter were -$19.98 million. In the same quarter last year, Kiniksa Pharmaceuticals's earnings per share (EPS) was -$0.61.

If you're new to stock investing, here's how to buy Kiniksa Pharmaceuticals stock.

What was KNSA's earnings growth in the past year?

As of Q3 2022, Kiniksa Pharmaceuticals's earnings has grown year over year. Kiniksa Pharmaceuticals's earnings in the past year totalled -$112.07 million.

What is KNSA's earnings date?

Kiniksa Pharmaceuticals's earnings date is Invalid Date. Add KNSA to your watchlist to be reminded of KNSA's next earnings announcement.

What was KNSA's revenue last quarter?

On Invalid Date, Kiniksa Pharmaceuticals (NASDAQ: KNSA) reported Q2 2022 revenue of $26.97 million up 250.1% year over year. In the same quarter last year, Kiniksa Pharmaceuticals's revenue was $7.70 million.

What was KNSA's revenue growth in the past year?

As of Q3 2022, Kiniksa Pharmaceuticals's revenue has grown 1,068.24% year over year. This is 52.48 percentage points lower than the US Biotechnology industry revenue growth rate of 1,120.72%. Kiniksa Pharmaceuticals's revenue in the past year totalled $90.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.